Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced the appointment of healthcare industry veterans Suja Chandrasekaran, MS and Scott Mendel,
Press release content from Business Wire. The AP news staff was not involved in its creation.
Personalis Announces Changes to its Board of Directors
March 8, 2021 GMT
MENLO PARK, Calif.--(BUSINESS WIRE)--Mar 8, 2021--
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced that it has appointed Dr. Woodrow (Woody) Myers to its Board of Directors and to the Nominating and Corporate Governance Committee of the Board. The company also announced that Patrick J. Balthrop has resigned his position as a director of the company, effective March 8, 2021.
Dr. Myers is currently the managing director of Myers Ventures LLC and has a long and distinguished career in the healthcare industry, most recently serving as the Chief Medical Officer and Chief Healthcare Strategist at Blue Cross & Blue Shield of Arizona. He has also held executive positions with Havencrest Healthcare Partners, Corizon Health, and Wellpoint Health Networks. He has served on multiple public, private, and nonprofit boards including Express Scripts, Genomic Health, LipoScience, and SynGen. In higher education he served on the Board of Trustees of Stanford University, the Board of Overseers of Harvard University, and the Board of Trustees of the Charles R. Drew University of Medicine and Science.